SEQENS has announced it has reached an agreement in principle on a comprehensive financial restructuring
PRESS RELEASE | ECULLY, FRANCE – August 5th, 2026
SEQENS has announced it has reached an agreement in principle on a comprehensive financial restructuring to strengthen its balance sheet and support its long-term strategy.
SEQENS today announced that it has reached an agreement in principle with all of its key financial stakeholders on the main terms of a comprehensive financial restructuring aimed at significantly strengthening the Group’s balance sheet, enhancing liquidity and supporting the delivery of its long-term strategic plan.
This important milestone reflects the strong support of the Group’s financial partners in SEQENS’ industrial capabilities, strategic market positions, customer relationships and in the strategic roadmap developed to secure the Group’s long-term future growth.
The contemplated transaction will provide SEQENS with a deleveraged and more sustainable capital structure aligned with the Group’s long-term development ambitions.
Upon completion of the contemplated restructuring, the Group’s senior lenders will become the new shareholders of SEQENS, reinforcing their long-term commitment to the Group’s future development.
Bpifrance will remain a key minority shareholder, providing continuity and ongoing institutional support alongside the incoming shareholders.
The strengthened financial position and new shareholding will provide SEQENS with improved flexibility and foundation to execute its strategic plan, continue investing in its industrial footprint, support innovation and maintain the highest standards of quality, reliability and customer service.
The transaction is financial in nature and is not intended to have any impact on the operational organization, employment, collective agreements, employee benefits or working conditions within the Group.
Pascal Villemagne, Chief Executive Officer of SEQENS, commented:
“This agreement in principle marks a decisive step forward for SEQENS. It provides the Group with a significantly stronger capital structure and the means to accelerate the execution of its strategic plan. Our focus remains firmly to serve our customers and strengthen our industrial operations. With the support of our financial stakeholders and Bpifrance, we are reinforcing our strategic positions in pharmaceutical solutions and specialty ingredients. I would like to thank our employees, customers, suppliers and financial partners for their long trust and commitment. Their support has been instrumental in reaching this important milestone and will remain essential as we continue building the future of SEQENS.”
The completion of the transaction is currently expected by the end of 2026, subject to the required procedural and legal approvals necessary to implement the contemplated restructuring and the completion conditions customarily applicable to this type of transaction. Additional information is available for creditors only at seqens@is.kroll.com.
This press release is for informational purposes only and does not constitute, or form part of, an offer to sell or issue, or the solicitation of an offer to purchase, subscribe for or otherwise acquire, any securities in any jurisdiction, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.
